
Advos
Advos.io
@advos
22138 articles
Articles

Soligenix's HyBryte Shows Superior Efficacy and Safety Over Valchlor in CTCL Treatment Study
Soligenix Inc. has published positive results from its comparability study evaluating HyBryte versus Valchlor for the treatment of cutaneous T-cell lymphoma in Oncology and Therapy, revealing significantly better efficacy and safety outcomes for its investigational therapy. After 12 weeks of treatment, 60% of HyBryte-treate...
April 2, 2026Read more

Planet Ventures Invests $250,000 in AI Space Software Company Antaris
Planet Ventures Inc. (CSE: PXI) (OTC Pink: PNXPF) (FSE: P6U) has announced a strategic investment of $250,000 in Antaris, an artificial intelligence-driven space mission software company. The investment follows the first close of Antaris's $28 million Series A financing round. This move provides Planet Ventures with exposur...
April 2, 2026Read more

NurExone Biologic Wins Healthcare Award, Expands Investor Outreach Strategy
NurExone Biologic Inc. has been recognized with first place in the Healthcare category at the BOLD Awards VII Gala, held on March 27, 2026, in Barcelona. The award acknowledges the company's leadership in developing exosome-based therapies for central nervous system injuries, a field with significant unmet medical needs. Th...
April 2, 2026Read more

American Fusion Nears Critical Fuel Agreements for Aneutronic Fusion Commercialization
American Fusion Inc. (OTC: AMFN) has reported it is in the final stages of securing multi-year supply agreements with a U.S.-based subsidiary of a global industrial organization for helium-3 and deuterium, key fuels for its Texatron aneutronic fusion system. This development represents a critical step in the company's path ...
April 2, 2026Read more

MAX Power Mining Advances Saskatchewan Natural Hydrogen Portfolio with New Discoveries and Expanded Exploration
MAX Power Mining Corp. has reported multiple milestones that advance the scale and commercial potential of its Saskatchewan-based natural hydrogen portfolio, backed by a recent $20.5 million financing. The company's progress includes successful drilling at the Bracken Well, completion of a high-resolution 3D seismic survey ...
April 2, 2026Read more

Lantern Pharma to Demonstrate AI Co-Scientist Platform in April Investor Briefing
Lantern Pharma Inc. (NASDAQ: LTRN) announced it will host an investor, analyst and shareholder briefing on April 9, 2026, featuring a live demonstration of withZeta.ai, described as the first multi-agentic AI co-scientist for rare cancer drug discovery, development and clinical trial design. The event will include participa...
April 2, 2026Read more

Lantern Pharma to Demonstrate AI Co-Scientist Platform in April Investor Briefing
Lantern Pharma Inc. (NASDAQ: LTRN) announced it will host an investor, analyst and shareholder briefing on April 9, 2026, featuring a live demonstration of withZeta.ai, described as the first multi-agentic AI co-scientist for rare cancer drug discovery, development and clinical trial design. The webcast will highlight the p...
April 2, 2026Read more

Nevada Organic Phosphate Targets Growing Organic Fertilizer Supply Gap with Nevada Project
The organic agriculture sector's rapid expansion has created a significant supply challenge for certified inputs, particularly phosphate fertilizer that meets organic certification standards. Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) is positioning its Murdock Mountain project in northeastern Nevada as a poten...
April 2, 2026Read more

Datavault AI Partners with Demora Foundation to Tokenize K-Entertainment Assets
Datavault AI Inc. (NASDAQ: DVLT) has entered into a Technology Integration Agreement with Demora Foundation to serve as the formal AI data intelligence and real-world asset (RWA) tokenization technology partner for the K-Entertainment & K-Wave Global Platform. The partnership will leverage Datavault AI's enterprise AI stack...
April 2, 2026Read more

California Taxpayer-Funded Therapy Receives FDA Approval for Rare Childhood Disease
The California Institute for Regenerative Medicine (CIRM) has reached a significant milestone with the U.S. Food and Drug Administration granting accelerated approval to KRESLADI, a one-time therapy developed by Rocket Pharmaceuticals to treat severe leukocyte adhesion deficiency-I (LAD-I) in children. This marks the first ...
April 2, 2026Read more

Sigyn Therapeutics Launches Initiative to Evaluate Medical Technologies for CTE in Former NFL Players
Sigyn Therapeutics has announced the launch of an initiative to evaluate emerging medical technologies in former NFL players at risk of chronic traumatic encephalopathy. This initiative is significant as it addresses a critical health issue affecting former professional athletes who experience significantly higher rates of ...
April 2, 2026Read more

CHARBONE Expands Helium Distribution in Ontario Amid Global Supply Constraints
CHARBONE Corporation has refilled a dedicated helium trailer to serve an existing customer in Ontario, confirming the commercial continuity of its Helium division launched in 2025. This operation aligns with the Company's strategy to build an integrated platform for distributing strategic industrial gases across North Ameri...
April 2, 2026Read more
Retail Veteran Mitch Gould's Distribution Platform Addresses Growing Complexity in U.S. Sports Nutrition Market
Industry veteran behind Evolution of Distribution shares insights on what separates successful sports nutrition brands in the U.S.
April 2, 2026Read more

Santos Muscle Nutrition Announces Walmart.com Expansion in U.S. Market
Dutch sports nutrition brand Santos Muscle Nutrition plans expanded U.S. access through Walmart.com.
April 2, 2026Read more

ORGANA International Expands Mineral Drink Availability on OneLavi Platform for U.S. Wellness Consumers
Plant-derived mineral drink with fulvic acid now accessible on OneLavi, supporting daily wellness routines.
April 2, 2026Read more

Ares Strategic Mining Bolsters Investor Relations Team Following $10 Million Funding
Ares Strategic Mining Inc. has announced the introduction of a new Investor Relations Team, a strategic move enabled by the Company's recent $10 million funding. This development is significant as it positions the mining company to better support its expanding shareholder base while pursuing ambitious growth objectives, inc...
April 2, 2026Read more

Carmed Pharmaceuticals Expands U.S. Distribution Through Amazon Launch of Research-Based Botanical Formulations
Standardized carvacrol formulations to be available soon on Amazon as Carmed broadens U.S. distribution.
April 2, 2026Read more

Symbio's Temecula Expansion Highlights Clean Energy Shift in Southern California Wine Country
The SoCal Wine Country Economic Development Coalition has highlighted Symbio's expansion in Temecula as evidence of the region's growing prominence in clean technology. Symbio, a hydrogen fuel cell company, established its North American headquarters in Temecula two years ago, representing a significant development for both...
April 1, 2026Read more

Leonteq Shareholders Approve All Board Proposals at 2026 Annual Meeting
Shareholders of Leonteq AG demonstrated strong support for the company's leadership and strategic direction at the 2026 Annual General Meeting, approving all proposals put forward by the Board of Directors. The meeting, held in Zurich, saw approximately 64% of issued shares represented through 102 shareholders personally at...
April 1, 2026Read more

LION E-Mobility Reports Strong 2025 Financial Turnaround with 68% Revenue Growth
LION E-Mobility AG, a manufacturer of battery packs for electric mobility and energy storage solutions, reported substantial financial improvement in its 2025 fiscal year, with preliminary figures showing total revenue reaching €28.3 million, representing a 68% increase from €16.9 million in 2024. The company's EBITDA impro...
April 1, 2026Read more

Springer Nature CFO Alexandra Dambeck to Depart by End of 2026
Alexandra Dambeck has decided to step down from her role as Chief Financial Officer of Springer Nature and as a member of the Management Board to pursue a new external opportunity. Her departure is scheduled for the fourth quarter of 2026, with the specific end date to be confirmed later. Dambeck will remain in her position...
April 1, 2026Read more

